Phase II trial of clofarabine and daunorubicin as induction therapy for acute myeloid leukemia patients greater than or equal to 60 years of age
| Autor: | Vigil, Carlos E., Tan, Wei, Deeb, George, Sait, Sheila N., Block, Annemarie W., Starostik, Petr, Griffiths, Elizabeth A., Thompson, James E., Greene, Jessica D., Ford, Laurie A., Wang, Eunice S., Wetzler, Meir |
|---|---|
| Zdroj: | In Leukemia Research November 2013 37(11):1468-1471 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect